<DOC>
	<DOC>NCT01659307</DOC>
	<brief_summary>This is a double-blind, placebo-controled, randomized trial to investigate if aspirin pre-treatment has anti-inflammatory effects in a model of acute lung injury induced by inhaled endotoxin (LPS) in healthy human volunteers.</brief_summary>
	<brief_title>The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Healthy subjects Age &lt; 18 years Pregnancy or breast feeding or woman of childbearing potential not using adequate contraception. Participation in a clinical trial of an investigational medicinal product within 30 days Consent declined Aspirin or non steroidal antiinflammatory (NSAID) use in the past 4 weeks History of asthma Known aspirin or NSAID hypersensitivity History of peptic ulcer disease Platelet count &lt; 150 x 106/ml Aspirin resistance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute Lung Injury</keyword>
	<keyword>Acute Respiratory Distress Syndrome</keyword>
	<keyword>Aspirin</keyword>
</DOC>